Literature DB >> 18216108

A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication.

Toru Okamoto1, Hiroko Omori, Yuuki Kaname, Takayuki Abe, Yorihiro Nishimura, Tetsuro Suzuki, Tatsuo Miyamura, Tamotsu Yoshimori, Kohji Moriishi, Yoshiharu Matsuura.   

Abstract

Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) regulates viral replication through its interaction with host and other viral proteins. We have previously shown that FK506-binding protein 8 (FKBP8) binds to NS5A and recruits Hsp90 to form a complex that participates in the replication of HCV. In this study, we examined the biochemical characteristics of the interaction and the intracellular localization of NS5A and FKBP8. Surface plasmon resonance analysis revealed that the dissociation constant of the interaction between the purified FKBP8 and NS5A expressed in bacteria was 82 nM. Mutational analyses of NS5A revealed that a single amino acid residue of Val or Ile at position 121, which is well conserved among all genotypes of HCV, is critical for the specific interaction with FKBP8. Substitution of the Val(121) to Ala drastically impaired the replication of HCV replicon cells, and the drug-resistant replicon cells emerging after drug selection were shown to have reverted to the original arrangement by replacing Ala(121) with Val. Examination of individual fields of the replicon cells by both fluorescence microscopy and electron microscopy (the correlative fluorescence microscopy-electron microscopy technique) revealed that FKBP8 is partially colocalized with NS5A in the cytoplasmic structure known as the membranous web. These results suggest that specific interaction of NS5A with FKBP8 in the cytoplasmic compartment plays a crucial role in the replication of HCV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216108      PMCID: PMC2268450          DOI: 10.1128/JVI.02253-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

Authors:  K Moriya; H Yotsuyanagi; Y Shintani; H Fujie; K Ishibashi; Y Matsuura; T Miyamura; K Koike
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

2.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

3.  Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis.

Authors:  Hideki Aizaki; Keum S Choi; Minyi Liu; Yi-jia Li; Michael M C Lai
Journal:  J Biomed Sci       Date:  2006-05-12       Impact factor: 8.410

4.  Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex.

Authors:  Denise Egger; Benno Wölk; Rainer Gosert; Leonardo Bianchi; Hubert E Blum; Darius Moradpour; Kurt Bienz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.

Authors:  Daniel Lamarre; Paul C Anderson; Murray Bailey; Pierre Beaulieu; Gordon Bolger; Pierre Bonneau; Michael Bös; Dale R Cameron; Mireille Cartier; Michael G Cordingley; Anne-Marie Faucher; Nathalie Goudreau; Stephen H Kawai; George Kukolj; Lisette Lagacé; Steven R LaPlante; Hans Narjes; Marc-André Poupart; Jean Rancourt; Roel E Sentjens; Roger St George; Bruno Simoneau; Gerhard Steinmann; Diane Thibeault; Youla S Tsantrizos; Steven M Weldon; Chan-Loi Yong; Montse Llinàs-Brunet
Journal:  Nature       Date:  2003-10-26       Impact factor: 49.962

6.  The NS5A protein of hepatitis C virus is a zinc metalloprotein.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Alexander E Gorbalenya; Charles M Rice
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

7.  Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Charles M Rice
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

8.  Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.

Authors:  John M Robida; Heather B Nelson; Zhe Liu; Hengli Tang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

9.  Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus.

Authors:  Steeve Boulant; Paul Targett-Adams; John McLauchlan
Journal:  J Gen Virol       Date:  2007-08       Impact factor: 3.891

10.  Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; N Izumi; F Marumo; C Sato
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more
  20 in total

1.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells.

Authors:  Chikako Ono; Akinori Ninomiya; Satomi Yamamoto; Takayuki Abe; Xiauyu Wen; Takasuke Fukuhara; Miwa Sasai; Masahiro Yamamoto; Tatsuya Saitoh; Takashi Satoh; Taro Kawai; Ken J Ishii; Shizuo Akira; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.

Authors:  Michael R Defee; Zhiqiang Qin; Lu Dai; Jennifer S Isaacs; Chris H Parsons
Journal:  Am J Cancer Res       Date:  2011-06-05       Impact factor: 6.166

Review 4.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

Review 5.  Broad action of Hsp90 as a host chaperone required for viral replication.

Authors:  Ron Geller; Shuhei Taguwa; Judith Frydman
Journal:  Biochim Biophys Acta       Date:  2011-12-02

Review 6.  Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Authors:  Melanie Gerard; Angélique Deleersnijder; Jonas Demeulemeester; Zeger Debyser; Veerle Baekelandt
Journal:  Mol Neurobiol       Date:  2011-05-07       Impact factor: 5.590

7.  CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan.

Authors:  Takayuki Abe; Takasuke Fukuhara; Xiauyu Wen; Akinori Ninomiya; Kohji Moriishi; Yoshihiko Maehara; Osamu Takeuchi; Taro Kawai; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

8.  Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation.

Authors:  Kiyoko Okamoto; Yoshio Mori; Yasumasa Komoda; Toru Okamoto; Masayasu Okochi; Masatoshi Takeda; Tetsuro Suzuki; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Cochaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway.

Authors:  Shuhei Taguwa; Hiroto Kambara; Hiroko Omori; Hideki Tani; Takayuki Abe; Yoshio Mori; Tetsuro Suzuki; Tamotsu Yoshimori; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

Review 10.  Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases.

Authors:  Po-Yuan Ke; Steve S-L Chen
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.